Overview

Budesonide Treatment for Lymphocytic Colitis

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether orale budesonide is effective in the treatment of lymphocytic colitis
Phase:
Phase 3
Details
Lead Sponsor:
Technische Universität Dresden
Collaborator:
Dr. Falk Pharma GmbH
Treatments:
Budesonide